NeuroBo Pharmaceuticals Inc (NRBO)
2.27
-0.12
(-5.02%)
USD |
NASDAQ |
Nov 15, 12:35
NeuroBo Pharmaceuticals Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | -0.003M |
| March 31, 2024 | -0.005M |
| December 31, 2023 | -0.009M |
| September 30, 2023 | -0.037M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -0.004M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.008M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.583M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.003M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.071M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.002M |
| December 31, 2019 | -5.939M |
| Date | Value |
|---|---|
| September 30, 2019 | -0.093M |
| June 30, 2019 | -0.025M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.003M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.939M
Minimum
Dec 2019
0.071M
Maximum
Dec 2020
-0.3253M
Average
--
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| Cytokinetics Inc | -45.05M |
| Ocugen Inc | -0.513M |
| enVVeno Medical Corp | 6.22M |
| Scholar Rock Holding Corp | 50.62M |
| Mirum Pharmaceuticals Inc | -72.72M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.589M |
| Cash from Financing (Quarterly) | -0.676M |
| Free Cash Flow | -22.69M |
| Free Cash Flow Per Share (Quarterly) | -0.5472 |
| Free Cash Flow Yield | -154.8% |